Hemab Therapeutics Holdings, Inc. Common Stock (COAG) Technical Analysis & Indicators
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) — Price $43.10 (closing price, November 3, 2026) — Healthcare — Biotechnology — NASDAQ
Latest reported results:
Technical analysis of Hemab Therapeutics Holdings, Inc. Common Stock (COAG): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody.